CTLA-4 Ig | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

19,212 results for “CTLA-4 Ig”

Trials

View all 7447 →

Intravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes Mellitus

112 participants · First posted Jul 23, 2007

Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation

41 participants · First posted Aug 24, 2023

Active, not recruiting

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer

499 participants · First posted Mar 1, 2019

Drugs

View all 4582 →

RG-2077

Recombinant human CTLA4-Ig Fusion protein（Shanghai CP Guojian）

Organizations

View all 1603 →

Xi'an No.4 Hospital

China

Guiyang No.4 People's Hospital

China

Huai'an No.4 People's Hospital

China

News

View all 5580 →

Coya Therapeutics Raises $23 Million to Advance ALS Treatment Development

Coya Therapeutics Awaits FDA Decision on ALS Treatment as Q2 Results Show Mixed Performance

Coya Therapeutics Secures Key Patent for IL-2 Liquid Formulation, Advances ALS Combination Therapy

Page 1 of 1922